TGFB1 and cancer: FNDC3B is contained in the amplified region 3q26.1-q27.2, inducing the epithelial-to-mesenchymal transition (EMT) and activating several cancer pathways, including PI3-kinase/Akt, RB1 and TGFβ signaling [41].